Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory DiseasesLingfeng Chen, Guang Liang, Lin Ma et al.|Journal of Medicinal Chemistry|2024Cited by 6
Degradation of IRAK4 for the treatment of lipopolysaccharide-induced acute lung injury in miceBo Ye, Lulu Zheng|Frontiers in Pharmacology|2025Cited by 1